Hackensack University Medical Center is a 781-bed non-profit, research and teaching hospital providing tertiary and healthcare needs located seven miles west of New York City, in Hackensack, Bergen County, New Jersey. As of 2019, it ranks as the 2nd largest hospital in New Jersey and No. 59 in the US.

There are 781 beds in Hackensack University Medical Center.

During the past decade, Hackensack University Medical Center conducted 521 clinical trials. In the 10-year time frame, 521 clinical trials started and 360 clinical trials were completed, i.e. on average, 69.1% percent of trials that started reached the finish line to date. In the past 5 years, 198 clinical trials started and 184 clinical trials were completed. i.e. 92.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hackensack University Medical Center" #1 sponsor was "Children's Oncology Group" with 175 trials, followed by "National Cancer Institute (NCI)" with 125 trials sponsored, "Eastern Cooperative Oncology Group" with 48 trials sponsored, "Hackensack Meridian Health" with 40 trials sponsored and "Celgene" with 40 trials sponsored. Other sponsors include 710 different institutions and companies that sponsored additional 292 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hackensack University Medical Center" #1 collaborator was "National Cancer Institute (NCI)" with 326 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 17 trials as a collaborator, "Eastern Cooperative Oncology Group" with 15 trials as a collaborator, "Hackensack Meridian Health" with 15 trials as a collaborator and "SWOG Cancer Research Network" with 15 trials as a collaborator. Other collaborators include 475 different institutions and companies that were collaborators in the rest 275 trials.

According to Clinical.Site data, the most researched conditions in "Hackensack University Medical Center" are "Multiple Myeloma" (66 trials), "Leukemia" (51 trials), "Lymphoma" (44 trials), "Breast Cancer" (34 trials) and "Myelodysplastic Syndromes" (24 trials). Many other conditions were trialed in "Hackensack University Medical Center" in a lesser frequency.

Most popular intervention types in "Hackensack University Medical Center" are "Drug" (837 trials), "Biological" (280 trials), "Other" (227 trials), "Procedure" (177 trials) and "Radiation" (107 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (107 trials), "Cyclophosphamide" (71 trials), "cyclophosphamide" (65 trials), "Placebo" (53 trials) and "Quality-of-Life Assessment" (53 trials). Other intervention names were less common.

The vast majority of trials in "Hackensack University Medical Center" are 1057 trials for "All" genders, 62 trials for "Female" genders and 22 trials for "Male" genders.

Currently, there are NaN active trials in "Hackensack University Medical Center". undefined are not yet recruiting, 183 are recruiting, 221 are Active, not recruiting, and 7 are Enrolling by invitation. In total, there were 568 completed trials in Hackensack University Medical Center, 10 suspended trials, and 111 terminated clinical trials to date.

Out of the total trials that were conducted in Hackensack University Medical Center, 208 "Phase 1" clinical trials were conducted, 473 "Phase 2" clinical trials and 359 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 17 trials, and there were also 98 trials that are defined as “Not Applicable".

Hackensack University Medical Center has several departments that took part in Clinical trials: "John Theurer Cancer Center at Hackensack University Medical Center" - 167 trials, "Meridian Health" - 3 trials, "Hackensack University Medical Center Multiple Myeloma Division" - 2 trials, "JFK Johnson Rehabilitation Institute" - 2 trials